Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 2913 | 47.2 |
09:34 ET | 1520 | 46.805 |
09:36 ET | 300 | 46.8573 |
09:38 ET | 300 | 47.025 |
09:39 ET | 2893 | 46.84 |
09:41 ET | 11179 | 46.42 |
09:43 ET | 5627 | 46.12 |
09:45 ET | 7100 | 46.1591 |
09:48 ET | 11257 | 45.69 |
09:50 ET | 7019 | 45.83 |
09:52 ET | 2497 | 46.27 |
09:54 ET | 6600 | 46.29 |
09:56 ET | 9085 | 46.475 |
09:57 ET | 7851 | 46.53 |
09:59 ET | 1090 | 46.53 |
10:01 ET | 100 | 46.53 |
10:03 ET | 400 | 46.49 |
10:06 ET | 2961 | 46.44 |
10:08 ET | 8436 | 46.435 |
10:10 ET | 6561 | 46.36 |
10:12 ET | 6103 | 46.585 |
10:14 ET | 1842 | 46.575 |
10:15 ET | 1409 | 46.5 |
10:17 ET | 1200 | 46.5 |
10:19 ET | 1103 | 46.565 |
10:21 ET | 6901 | 46.75 |
10:24 ET | 6950 | 46.745 |
10:26 ET | 4527 | 46.635 |
10:28 ET | 32542 | 46.69 |
10:30 ET | 12200 | 47 |
10:32 ET | 5534 | 46.995 |
10:33 ET | 42564 | 47.495 |
10:35 ET | 4054 | 47.52 |
10:37 ET | 3946 | 47.71 |
10:39 ET | 1600 | 47.91 |
10:42 ET | 1334 | 47.89 |
10:44 ET | 1544 | 48.2 |
10:46 ET | 1684 | 48.08 |
10:48 ET | 2079 | 48.005 |
10:50 ET | 2415 | 48.16 |
10:51 ET | 100 | 48.2 |
10:53 ET | 2427 | 48.06 |
10:55 ET | 5737 | 48.1 |
10:57 ET | 800 | 48.3 |
11:00 ET | 100 | 48.36 |
11:02 ET | 4821 | 48.34 |
11:04 ET | 1100 | 48.315 |
11:06 ET | 300 | 48.305 |
11:08 ET | 2747 | 48.465 |
11:09 ET | 2277 | 48.435 |
11:11 ET | 2150 | 48.435 |
11:13 ET | 600 | 48.33 |
11:15 ET | 2000 | 48.5 |
11:18 ET | 800 | 48.54 |
11:20 ET | 1100 | 48.46 |
11:22 ET | 2611 | 48.37 |
11:24 ET | 1600 | 48.36 |
11:26 ET | 4003 | 48.39 |
11:27 ET | 1116 | 48.42 |
11:29 ET | 1000 | 48.375 |
11:33 ET | 2179 | 48.28 |
11:36 ET | 1572 | 48.24 |
11:38 ET | 200 | 48.205 |
11:40 ET | 3100 | 48.27 |
11:42 ET | 100 | 48.275 |
11:44 ET | 600 | 48.27 |
11:45 ET | 100 | 48.285 |
11:47 ET | 619 | 48.285 |
11:49 ET | 300 | 48.28 |
11:51 ET | 800 | 48.28 |
11:54 ET | 2545 | 48.185 |
11:56 ET | 5800 | 48.3 |
11:58 ET | 900 | 48.31 |
12:00 ET | 400 | 48.35 |
12:02 ET | 638 | 48.33 |
12:03 ET | 2100 | 48.515 |
12:05 ET | 600 | 48.56 |
12:07 ET | 2544 | 48.505 |
12:09 ET | 3800 | 48.495 |
12:12 ET | 401 | 48.43 |
12:14 ET | 300 | 48.46 |
12:16 ET | 500 | 48.48 |
12:18 ET | 500 | 48.43 |
12:20 ET | 1275 | 48.36 |
12:21 ET | 973 | 48.37 |
12:23 ET | 3693 | 48.12 |
12:25 ET | 2981 | 48.17 |
12:27 ET | 3495 | 48.32 |
12:30 ET | 1200 | 48.335 |
12:32 ET | 2565 | 48.22 |
12:34 ET | 1850 | 48.15 |
12:36 ET | 3264 | 47.98 |
12:38 ET | 200 | 47.93 |
12:39 ET | 2593 | 47.945 |
12:43 ET | 2726 | 48.03 |
12:45 ET | 1975 | 47.84 |
12:48 ET | 100 | 47.85 |
12:50 ET | 2320 | 47.825 |
12:52 ET | 800 | 47.8 |
12:54 ET | 900 | 47.71 |
12:56 ET | 700 | 47.78 |
12:57 ET | 1079 | 47.695 |
12:59 ET | 300 | 47.64 |
01:01 ET | 100 | 47.63 |
01:03 ET | 1725 | 47.38 |
01:06 ET | 8300 | 47.56 |
01:08 ET | 2160 | 47.515 |
01:10 ET | 900 | 47.52 |
01:12 ET | 12581 | 47.785 |
01:14 ET | 332 | 47.795 |
01:15 ET | 400 | 47.75 |
01:17 ET | 200 | 47.785 |
01:19 ET | 400 | 47.85 |
01:21 ET | 560 | 47.8401 |
01:24 ET | 200 | 47.915 |
01:26 ET | 200 | 47.9 |
01:28 ET | 2500 | 48.035 |
01:30 ET | 400 | 48.085 |
01:32 ET | 100 | 48.075 |
01:33 ET | 4822 | 48.025 |
01:35 ET | 5048 | 48.045 |
01:39 ET | 600 | 48.03 |
01:42 ET | 3454 | 48.17 |
01:44 ET | 2510 | 48.32 |
01:46 ET | 2300 | 48.38 |
01:48 ET | 1462 | 48.38 |
01:50 ET | 100 | 48.38 |
01:51 ET | 2927 | 48.53 |
01:53 ET | 200 | 48.545 |
01:55 ET | 600 | 48.555 |
01:57 ET | 700 | 48.53 |
02:00 ET | 530 | 48.455 |
02:02 ET | 300 | 48.45 |
02:04 ET | 960 | 48.45 |
02:06 ET | 100 | 48.45 |
02:08 ET | 4400 | 48.525 |
02:09 ET | 300 | 48.52 |
02:11 ET | 1000 | 48.59 |
02:13 ET | 2746 | 48.62 |
02:15 ET | 1794 | 48.64 |
02:18 ET | 300 | 48.62 |
02:20 ET | 880 | 48.64 |
02:22 ET | 3083 | 48.64 |
02:24 ET | 1200 | 48.685 |
02:26 ET | 1342 | 48.735 |
02:27 ET | 700 | 48.74 |
02:29 ET | 500 | 48.7 |
02:31 ET | 300 | 48.735 |
02:33 ET | 300 | 48.7 |
02:36 ET | 500 | 48.74 |
02:38 ET | 200 | 48.71 |
02:40 ET | 500 | 48.7 |
02:42 ET | 600 | 48.745 |
02:44 ET | 700 | 48.745 |
02:45 ET | 4900 | 49.14 |
02:47 ET | 1900 | 49.065 |
02:49 ET | 2913 | 49.055 |
02:51 ET | 1511 | 49.0668 |
02:54 ET | 400 | 49.05 |
02:56 ET | 3642 | 49.09 |
02:58 ET | 786 | 49.02 |
03:00 ET | 3600 | 49.18 |
03:02 ET | 1544 | 49.27 |
03:03 ET | 400 | 49.265 |
03:05 ET | 2464 | 49.11 |
03:07 ET | 1666 | 49.185 |
03:09 ET | 6649 | 49.045 |
03:12 ET | 1799 | 49.03 |
03:14 ET | 2113 | 48.9 |
03:16 ET | 4971 | 48.94 |
03:18 ET | 3478 | 48.96 |
03:20 ET | 912 | 48.96 |
03:21 ET | 3020 | 48.865 |
03:23 ET | 8476 | 48.87 |
03:25 ET | 1937 | 48.9 |
03:27 ET | 2309 | 48.875 |
03:30 ET | 4437 | 49.055 |
03:32 ET | 500 | 49.08 |
03:34 ET | 1700 | 49.005 |
03:36 ET | 4130 | 49.0575 |
03:38 ET | 900 | 49.065 |
03:39 ET | 700 | 49.055 |
03:41 ET | 8353 | 49.09 |
03:43 ET | 1800 | 49.12 |
03:45 ET | 600 | 49.12 |
03:48 ET | 4557 | 48.91 |
03:50 ET | 4184 | 49.04 |
03:52 ET | 5457 | 48.91 |
03:54 ET | 8732 | 48.83 |
03:56 ET | 10075 | 48.82 |
03:57 ET | 6131 | 48.73 |
03:59 ET | 107346 | 48.68 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 8.8B | -31.1x | --- |
Ascendis Pharma A/S | 8.9B | -15.3x | --- |
Tempus AI Inc | 8.2B | -6.2x | --- |
Intra-Cellular Therapies Inc | 7.7B | -84.2x | --- |
Revolution Medicines Inc | 7.5B | -12.6x | --- |
Blueprint Medicines Corp | 5.7B | -26.5x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.8B |
---|---|
Revenue (TTM) | $456.0M |
Shares Outstanding | 184.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-1.57 |
Book Value | $6.88 |
P/E Ratio | -31.1x |
Price/Sales (TTM) | 19.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.